Evaluating pain management after a specific nerve block for hip surgery
Quality Of Recovery After Pericapsular Nerve Group (PENG) Block For Hip Hemiarthroplasty Under Spinal Anesthesia: A Prospective, Double-Blinded, Randomized Controlled Trial
This study is testing whether a new nerve block technique can help reduce pain and improve recovery for patients having hip surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Fayoum University Hospital Academic / other |
| Locations | 1 site (Madīnat Al Fayyūm, Fayoum Governorate) |
| Trial ID | NCT06369948 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of the Pericapsular Nerve Group (PENG) block in managing pain for patients undergoing elective hip hemiarthroplasty under spinal anesthesia. The study will involve 60 participants, who will be randomly assigned to either receive the PENG block or not, allowing for a comparison of recovery quality and pain levels. Data will be collected on various demographic and medical history factors, and patients will be monitored throughout the procedure. The trial aims to provide insights into the benefits of this novel nerve block technique in enhancing postoperative recovery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with ASA physical status 1-3 undergoing elective hip hemiarthroplasty.
Not a fit: Patients with ASA physical status 4 or above, or those with contraindications to spinal anesthesia will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved pain management and faster recovery for patients undergoing hip surgery.
How similar studies have performed: Other studies have shown promising results with similar regional anesthesia techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * - patients 18 years old or older with ASA physical status 1-3, patients who had no contraindications for spinal anesthesia, and patients undergoing elective surgery. Exclusion Criteria: * Patients with ASA physical status 4 or above. * Pre-existing anatomical or neurological deficits in the lower extremity. * Intolerance or allergy to local anesthetics. * Narcotic dependency. * Coagulopathy or using antiplatelet or anticoagulant medications. * Neuromuscular diseases. * Psychiatric illnesses (schizophrenia, bipolar, uncontrolled anxiety or depression). * Systemic infections or infections at site of injection.
Where this trial is running
Madīnat Al Fayyūm, Fayoum Governorate
- Fayoum University Hospital — Madīnat Al Fayyūm, Fayoum Governorate, Egypt (Recruiting)
Study contacts
- Principal investigator: Atef Mohamed Sayed, MS.C — Faculty of medicine, Fayoum university
- Study coordinator: Asmaa Taha Ali, M.B.B.C.H
- Email: ata14@fayoum.edu.eg
- Phone: 01030195623
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.